Skip to content

Evaluation of the Efficacy and Tolerance of Plasmapheresis by Double Cascade Filtration in a University Centre

Evaluation of the Efficacy and Tolerance of Plasmapheresis by Double Cascade Filtration in a University Centre

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04261205
Acronym
DFPPSURV
Enrollment
70
Registered
2020-02-07
Start date
2018-08-04
Completion date
2020-11-13
Last updated
2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure

Keywords

Chronic hemodialysis

Brief summary

A study is being carried out to evaluate the biological, technical and clinical/biological efficacy of this technique, the practice of which is standardized in the department, in order to evaluate our practices and to improve them if necessary. As part of this study, the investigators will ask all patients scheduled for this procedure to participate in this observational prospective study without changing usual practices.

Detailed description

The objective of the study is to conduct a prospective evaluation of the practice of apheresis by Double Filtration System Cascade system in a university centre in current practice with evaluation of the technical and biological effectiveness as the main objective and clinical and biological tolerance as the secondary objective for all consecutive sessions performed in a university centre over a period of 1 year.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to 99 Years

Inclusion criteria

Over 18 years of age I indication for plasmapheresis and hospitalized at Chu de Nimes.

Exclusion criteria

Under guardianship or curatorship Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Apheresis by DFPP and biological efficiencyover a period of one yearquantification of the purification carried out (volume)

Secondary

MeasureTime frameDescription
Clinical side effectswithin 1 hour of all sessioncatheter dysfunction
Biological side effectswithin 1 hour of all sessionBleeding rate
variation of Hb, platelet and albumin before and after sessionwithin 1 hour of all session% of Hb, platelet and albumin

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026